Radioiodine treatment outcome by dosimetric parameters and renal function in hyperthyroidism

BACKGROUND: Hyperthyroidism has been treated with radioiodine therapy for eight decades, with known benefits and side-effects. No consensus exists on which activity dosage and pre-therapeutic measurements are required for optimal treatment, balancing risk of incomplete response, therapy-induced hypo...

Descripción completa

Detalles Bibliográficos
Autores principales: Nilsson, Joachim N., Elovsson, Rebecca, Thor, Daniel, Calissendorff, Jan, Ardenfors, Oscar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9036725/
https://www.ncbi.nlm.nih.gov/pubmed/35462539
http://dx.doi.org/10.1186/s13044-022-00126-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9036725/
https://www.ncbi.nlm.nih.gov/pubmed/35462539
http://dx.doi.org/10.1186/s13044-022-00126-4

Ejemplares similares